EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Arrhythmia-Induced Cardiomyopathy Using Magnetic Resonance Imaging in Patients with Persistent Atrial Fibrillation and Left Ventricular Systolic Dysfunction – Insights from DECAAF II

Ala Assaf iD, Han Feng, Mayana Bsoul, Ghassan Bidaoui, Hadi Younes, Christian Massad, Mario Mekhael, Charbel Noujaim, Omar Kreidieh, Swati Rao, Amitabh Pandey, Philipp Sommer und 3 weitere

European Journal of Heart Failure · 01.09.2025 · 27 (9) · 1622-1632

DOI: 10.1002/ejhf.3684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 12.05.2025. Verfasst von Ala Assaf und 14 weiteren Autor:innen. Beteiligte Einrichtung: Tulane Research Innovation for Arrhythmia Discovery (TRIAD), Tulane University School of Medicine, New Orleans, LA, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathies, Ventricular Dysfunction, Left, Magnetic Resonance Imaging, Cine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atrial fibrillation (AF) ablation in heart failure reduces mortality and hospitalizations and improves ejection fraction. Arrhythmia-induced cardiomyopathy (AIC) is diagnosed after complete recovery of left ventricular systolic function after ablation. We aimed to identify the prevalence and pre-ablation predictors of AIC among patients with AF and left ventricular systolic dysfunction (LVSD). Methods and results We utilized the DECAAF II database, where 815 patients with persistent AF underwent late gadolinium enhancement cardiac magnetic-resonance imaging (LGE-CMR) before and 3 months after AF ablation. We only included patients with available left ventricular ejection fraction (LVEF) and LVSD. AF burden was continuously monitored. AIC was defined as LVSD and coexisting AF in patients with ejection fraction improvement to ≥50% following ablation. We identified 119 patients with LVSD and AF with a mean LVEF of 39.1 ± 7.8% and mean baseline fibrosis of 20.0 ± 7.3%. Mean AF burden post-ablation was 16.8 ± 20.2%, and mean LVEF recovery was 13.9 percentage points. Seventy-two patients (60.5%) fulfilled the criteria for AIC, and 47 (39.5%) did not. AIC patients had a mean baseline LVEF of 39.1 ± 7.9% (vs. 39.2 ± 7.9% in non-AIC patients; p = 0.9), a significantly lower percentage of fibrosis in the left atrial septal wall (12.2 ± 10.0% vs. 20.7 ± 11.4% in non-AIC patients, p < 0.001). Additionally, LVEF improvement was correlated with lower AF burden post-ablation (r = −0.23, p = 0.02).

Conclusions

In this post-hoc analysis of the DECAAF II trial, we found that the majority of patients with LVSD and persistent AF have AIC rather than primary cardiomyopathy. We identified LGE-CMR as a differentiator between AIC and other cardiomyopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathiesVentricular Dysfunction, LeftMagnetic Resonance Imaging, CineVentricular Function, LeftHumansMaleFemaleMiddle AgedCatheter AblationStroke VolumeAgedRetrospective StudiesSystole

Stichwörter der Autor:innen

Atrial fibrillationAtrial fibrosisAtrial myopathyEjection fractionHeart failureVentricular dysfunction

Autor:innen und Institutionen

  • Tulane Research Innovation for Arrhythmia Discovery (TRIAD), Tulane University School of Medicine, New Orleans, LA, USA.
  • Cleveland Clinics Foundation, Cleveland, OH, USA.
  • Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Med. Fakultät OWL (Universität Bielefeld), Bad Oeynhausen, Germany.
  • Department of Cardiology, Klinikum Coburg, Coburg, Germany.

ORCID-Profile: Ala Assaf, Christian Sohns

Zitieren

APA

Assaf, A., Feng, H., Bsoul, M., Bidaoui, G., Younes, H., Massad, C., Mekhael, M., Noujaim, C., Kreidieh, O., Rao, S., Pandey, A., Sommer, P., Mahnkopf, C., Marrouche, N., & Sohns, C. (2025). Characterization of Arrhythmia-Induced Cardiomyopathy Using Magnetic Resonance Imaging in Patients with Persistent Atrial Fibrillation and Left Ventricular Systolic Dysfunction – Insights from DECAAF II. European Journal of Heart Failure, 27(9), 1622-1632. https://doi.org/10.1002/ejhf.3684

Vancouver

Assaf A, Feng H, Bsoul M, Bidaoui G, Younes H, Massad C, et al. Characterization of Arrhythmia-Induced Cardiomyopathy Using Magnetic Resonance Imaging in Patients with Persistent Atrial Fibrillation and Left Ventricular Systolic Dysfunction – Insights from DECAAF II. European Journal of Heart Failure. 2025;27(9):1622-1632. doi:10.1002/ejhf.3684

BibTeX
@article{Assaf2025,
  author = {Assaf, Ala and Feng, Han and Bsoul, Mayana and Bidaoui, Ghassan and Younes, Hadi and Massad, Christian and Mekhael, Mario and Noujaim, Charbel and Kreidieh, Omar and Rao, Swati and Pandey, Amitabh and Sommer, Philipp and Mahnkopf, Christian and Marrouche, Nassir and Sohns, Christian},
  title = {Characterization of Arrhythmia-Induced Cardiomyopathy Using Magnetic Resonance Imaging in Patients with Persistent Atrial Fibrillation and Left Ventricular Systolic Dysfunction – Insights from DECAAF II},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {9},
  pages = {1622--1632},
  doi = {10.1002/ejhf.3684}
}
Kostenlos starten →